Clinical Trials Browser

Osteosarcoma × Blood Component Removal × 90 days × Clear all

NCT07428993 2026-05-19

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

Phase 2 Recruiting

Osteosarcoma